Activated protein C for severe sepsis

N Engl J Med. 2002 Sep 26;347(13):1035-6. doi: 10.1056/NEJM200209263471315.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Clinical Trials as Topic*
  • Drug Approval
  • Humans
  • Intracranial Hemorrhages / chemically induced
  • Protein C / adverse effects
  • Protein C / therapeutic use*
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use*
  • Risk
  • Sepsis / drug therapy*
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated